Diacylglycerol production in Jurkat T-cells: Differences between CD3, CD2 and PHA activation pathways
- 10 January 1991
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 3 (1) , 35-40
- https://doi.org/10.1016/0898-6568(91)90005-f
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Structural Biology of CD2Immunological Reviews, 1989
- Cyclic AMP‐mediated alteration of the CD2 activation process in human T lymphocytes. Preferential inhibition of the phosphoinositide cycle‐related transduction pathwayEuropean Journal of Immunology, 1988
- Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanismCell, 1988
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- Signal Transduction in Human T LymphocytesImmunological Reviews, 1987
- Functional and Molecular Aspects of Human T Lymphocyte Activation via T3‐Ti and Tl1 PathwaysImmunological Reviews, 1987
- T‐Lymphocyte Activation: The Role of Protein Kinase C and the Bifurcating Inositol Phospholipid Signal Transduction PathwayImmunological Reviews, 1987
- Enhancement of natural killer function through activation of the T11 E rosette receptor.Journal of Clinical Investigation, 1987
- Transmembrane signalling via the T11‐dependent pathway of human T cell activation. Evidence for the involvement of 1,2‐diacylglycerol and inositol phosphatesEuropean Journal of Immunology, 1987
- Phytohemagglutinin induces rapid degradation of phosphatidylinositol 4, 5-bisphosphate and transient accumulation of phosphatidic acid and diacylglycerol in a human T lymphoblastoid cell line, CCRF-CEMBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983